Skip to content

Retatrutide 10mg Snap Pen

$300

In stock

Specifications: 

  • 0.1mg per click.**
  • Up to 60 clicks per dose.
RESEARCH PURPOSES ONLY

Retatrutide: The Triple‑Agonist

Triple Incretin–Glucagon Receptor Agonist for Metabolic Research (GLP-1 / GIP / Glucagon)

Retatrutide is a weekly, long-acting tri-agonist that activates GLP-1, GIP, and glucagon receptors—a next-generation tool for studying weight regulation, glycemia, energy expenditure, and hepatic fat metabolism. Our dual-chamber Snap Pen stores the peptide and bacteriostatic diluent separately; twist to snap the internal seal, gently invert to mix, then prime and dispense—preserving material integrity until first use.

How It Works (Mechanistic Context)

  • GLP-1R agonism → potentiates glucose-dependent insulin secretion, slows gastric emptying, reduces appetite/energy intake.

  • GIPR agonism → augments post-prandial insulin response and complements GLP-1 actions on glycemia.

  • Glucagon receptor (GCGR) agonism → increases energy expenditure and fatty-acid utilization; when balanced with GLP-1/GIP, supports weight-loss biology and hepatic lipid mobilization.

Suggested Research Applications (non-exhaustive)

  • Obesity & energy balance: appetite control, indirect calorimetry, substrate use, activity-independent EE.

  • Glycemic control: glucose-tolerance and clamp studies, β-cell function, incretin synergy.

  • Body-composition studies: DXA/MRI endpoints for fat mass and lean mass dynamics.

  • Hepatic steatosis / MAFLD models: liver-fat change and lipid flux with tri-agonism.

Key Features (for Research Use)

Technical Information

CAS Number:
2381089-83-2
PubChem CID:
171390338
Formula:
C221H342N46O68
Synonyms:
Retatrutide, 2381089-83-2, EX-A7826E, GTPL13769
0
    0
    Your Cart
    Your cart is emptyReturn to Shop